Introduction: Anti-IgE

By Bochner Bruce   Saini Sarbjit  

Clinical Reviews in Allergy and Immunology, Vol. 29, Iss. 1, 2005-02 ,pp. : 1-2

Humana Press, Inc

Access to resources Recommend Favorite

Safety and tolerability of omalizumab (Xolair®), a recombinant humanized monoclonal anti-IgE antibody

By Deniz Yamo   Gupta Niroo  

Clinical Reviews in Allergy and Immunology, Vol. 29, Iss. 1, 2005-02 ,pp. : 31-48

Humana Press, Inc

Access to resources Recommend Favorite

Tolerability of Retreatment with Omalizumab, a Recombinant Humanized Monoclonal Anti-IgE Antibody, during a Second Ragweed Pollen Season in Patients with Seasonal Allergic Rhinitis

By Nayak Anjuli   Casale Thomas   Miller S. David   Condemi John   McAlary Margaret   Fowler-Taylor Angel   Della Cioppa Giovanni   Gupta Niroo  

Allergy and Asthma Proceedings, Vol. 24, Iss. 5, 2003-09 ,pp. : 323-329

OceanSide Publications, Inc

Access to resources Recommend Favorite

IgE and IgG₄ Levels in Allergic Patients During Immunotherapy

By Paganelli R.   Sgambato F.   D'Offizi G. P.   Scott J. R.   Rock H. S.   Di Nunzio D.   Caporaso C.   Halpern G. M.  

Allergy and Asthma Proceedings, Vol. 8, Iss. 6, 1987-11 ,pp. : 393-400

OceanSide Publications, Inc

Access to resources Recommend Favorite

Anti–immunoglobulin E monoclonal antibody administered with immunotherapy

By Parks Kevin W.   Casale Thomas B.  

Allergy and Asthma Proceedings, Vol. 27, Iss. 2, 2006-03 ,pp. : 33-36

OceanSide Publications, Inc

Access to resources Recommend Favorite